TRPV4 and Hydrocephalus: They demonstrated that LPA can act as an agonist of TRPV4 in the choroid plexus and that treatment of their LPA-induced hydrocephalus model with a TRPV4 antagonist ameliorated the ICP and slowed CSF secretion rates.